Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Accumulated Expenses (2021 - 2025)

LifeStance Health (LFST) has disclosed Other Accumulated Expenses for 5 consecutive years, with $42.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 441.41% to $42.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.2 million, a 441.41% increase, with the full-year FY2025 number at $42.2 million, up 441.41% from a year prior.
  • Other Accumulated Expenses was $42.2 million for Q4 2025 at LifeStance Health, roughly flat from $42.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $43.3 million in Q3 2024 to a low of $2.0 million in Q4 2021.
  • A 5-year average of $19.3 million and a median of $11.3 million in 2025 define the central range for Other Accumulated Expenses.
  • Biggest YoY gain for Other Accumulated Expenses was 1467.69% in 2023; the steepest drop was 88.88% in 2023.
  • LifeStance Health's Other Accumulated Expenses stood at $2.0 million in 2021, then surged by 49.41% to $2.9 million in 2022, then soared by 1092.51% to $35.0 million in 2023, then tumbled by 77.74% to $7.8 million in 2024, then soared by 441.41% to $42.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Other Accumulated Expenses are $42.2 million (Q4 2025), $42.1 million (Q3 2025), and $11.3 million (Q2 2025).